ARDS, acute respiratory distress syndrome
[용어속성] Term
Airways management in SARS-COV-2 acute respiratory failure: A prospective observational multi-center study
Original Article
[키워드] airway management
ARDS, acute respiratory distress syndrome
CI, Confidence interval
COVID-19, Coronavirus disease 2019
CPAP, continuous positive airways pressure
Critical care
Cuidado crítico
DBP, diastolic blood pressure
ECG, Electrocardiography
EtCO2, end-tidal carbon dioxide
ETT, Emergency Endotracheal intubation
HFNO, High flow nasal oxygen
HR, heart rate
ICU, Intensive care unit
Infección por SARS-CoV
Insuficiencia respiratoria
Intubación traqueal
Manejo de la vía aérea
NIV, noninvasive ventilation
OR, odds ratio
PaO2/FiO2, arterial partial oxygen pressure / fraction of inspired oxygen
PCR, polymerase chain reaction
Respiratory failure
RR, respiratory rate
SARS-CoV infection
SARS-CoV2, severe acute respiratory syndrome coronavirus 2
SBP, systolic blood pressure
SpO2, Peripheral oxygen saturation
tracheal intubation
[DOI] 10.1016/j.medin.2022.07.002 PMC 바로가기 [Article Type] Original Article
[DOI] 10.1016/j.medin.2022.07.002 PMC 바로가기 [Article Type] Original Article
Animal Models for the Study of SARS-CoV-2–induced Respiratory Disease and Pathology
Overview
[키워드] ACE2, angiotensin-converting enzyme 2
AGM, African green monkey
ALI, Acute Lung Injury
ARDS, acute respiratory distress syndrome
BALF, bronchoalveolar lavage fluid
CARDS, COVID-19-associated acute respiratory distress syndrome
DAD, diffuse alveolar damage
DPI, days postinfection
GGO, ground glass opacities
S, spike glycoprotein
[DOI] 10.30802/AALAS-CM-22-000089 PMC 바로가기 [Article Type] Overview
[DOI] 10.30802/AALAS-CM-22-000089 PMC 바로가기 [Article Type] Overview
Eliminating Potential Effects of Other Infections during Selection of Nonhuman Primates for COVID-19 Research
Overview
[키워드] ABSL, animal biosafety level
ACE-2, angiotensin-converting enzyme
ARDS, acute respiratory distress syndrome
CNPRC, California National Primate Research Center
E, Envelope
ESR, Erythrocyte sedimentation rate
HAV, Hepatitis A virus
HBV, hepatitis B virus
HGF hepatocyte growth factor
HTLV, human T-cell lymphotropic virus
IFN, interferon
IL, interleukin
IP, Inducible Protein
M, matrix
MCP, monocyte chemotactic proteins
MCSF, macrophage colony-stimulating factor
MIP, macrophage inflammatory protein
N, nucleocapsid
NSP, Non-structural Proteins
RdRp, RNA-dependent RNA polymerase
S, spike
SARS-CoV-2, severe acute respiratory syndrome-coronavirus-2
SFV, simian foamy virus
SOP, standard operating procedures
SRV/D, simian retrovirus type D
STLV, simian T-lymphotropic virus
TB, Tuberculosis
TGF, Transforming growth factor
TMPRSS2 transmembrane serine protease 2
[DOI] 10.30802/AALAS-CM-21-000086 PMC 바로가기 [Article Type] Overview
[DOI] 10.30802/AALAS-CM-21-000086 PMC 바로가기 [Article Type] Overview
Reviving the mutual impact of SARS-COV-2 and obesity on patients: From morbidity to mortality
Review
Published on
Journal: Biomedicine & pharmacotherapy = Biomédecine & phar [Category] COVID19(2023년), MERS, SARS,
Journal: Biomedicine & pharmacotherapy = Biomédecine & phar [Category] COVID19(2023년), MERS, SARS,
[키워드] ACE-2, Angiotensin-Converting Enzyme-2
Ang II, Angiotensin II
ARDS, acute respiratory distress syndrome
BMI, Body mass index
CI, Confidence interval
COPD, Chronic obstructive pulmonary disease
CVD, cardiovascular disease
EAT, Epicardial Adipose Tissue
ERV, Expiratory Reserve Volume
FRC, Functional Residual Capacity
HFD, High-Fat Diet
IFNs, Interferons
IL-6, Interleukin-6
Inflammation
JAK, Janus kinase
obesity
OR, Odds Ratio IMV: Intermittent Mandatory Ventilation
pandemic
RAAS, renin-angiotensin-aldosterone system
Respiratory compliance
SARS-CoV-2
SARS-COV-2, severe acute respiratory syndrome coronavirus-2
[DOI] 10.1016/j.biopha.2022.113178 PMC 바로가기 [Article Type] Review
[DOI] 10.1016/j.biopha.2022.113178 PMC 바로가기 [Article Type] Review
Recent advances in passive immunotherapies for COVID-19: The Evidence-Based approaches and clinical trials
Review
Published on
Journal: International immunopharmacology [Category] COVID19(2023년), SARS, 변종, 임상, 치료제,
Journal: International immunopharmacology [Category] COVID19(2023년), SARS, 변종, 임상, 치료제,
[키워드] 2019-nCoV, 2019 novel coronavirus
Abstract
accompany
ACE-2, Angiotensin-Converting Enzyme-2
acute respiratory disease syndrome
acute respiratory distress
acute respiratory syndrome
ADE, Antibody-dependent enhancement
adverse effect
AE(s), Adverse effect(s)
AEs
approach
ARDS
ARDS, acute respiratory distress syndrome
CAR, Chimeric antigen receptor
Cellular Immunotherapy
clinical trial
Community
complementary
Convalescent plasma (CP) therapy
coronavirus
COVID-19
COVID-19 vaccination
COVID-19 vaccines
COVID-19, Coronavirus disease 2019
CPT, Convalescent plasma therapy
CRP, C-reactive protein
CRS, Cytokine release syndrome
CT(s), Clinical trial(s)
Cytokine storm
Efficacy
effort
emerging disease
epidemiological
ESR, Erythrocyte sedimentation rate
FCR, Fc receptor
FDA, Food and Drug Administration
global pandemic
GM-CSF, granulocyte-macrophage colony-stimulating factor
group
GVHD, Graft-versus-host disease
HBV, Hepatitis B
HCV, Hepatitis C
highlight
HIV, Human immunodeficiency virus
HLH, Hemophagocytic lymphohistiocytosis
Human
I.V., Intravenous
IBD, Inflammatory bowel disease
IFN, interferon
IGG, immunoglobulin g
immunomodulation
Immunotherapy
Inflammation
inhibiting
International
investigated
IVIG, intravenous immunoglobulin
LAG-3, Lymphocyte-activation gene 3
LDH, lactate dehydrogenase
mAb(s), Monoclonal antibody(s)
MERS-COV, Middle East respiratory syndrome-corona virus
monoclonal antibody
MV, Mechanical ventilation
Passive
Passive immunotherapy
PCR, polymerase chain reaction
PD-1, Programmed cell death protein-1
platform
RA, Rheumatoid arthritis
RBD, receptor-binding domain
recent
reduced
SARS-CoV-2
SARS-CoV-2, Severe acute respiratory syndrome coronavirus 2
syndrome
TIM-3, T cell immunoglobulin domain and mucin domain-3
TNF, Tumor Necrosis Factor
TRALI, Transfusion-related acute lung injury
treating COVID-19 patient
Treatment
Vaccine
variants of SARS-CoV-2
VEGF, Vascular endothelial growth factor
Viral load
viral neutralization
[DOI] 10.1016/j.intimp.2022.108786 PMC 바로가기 [Article Type] Review
[DOI] 10.1016/j.intimp.2022.108786 PMC 바로가기 [Article Type] Review
A network biology approach to identify crucial host targets for COVID-19
Article
[키워드] 2019-nCoV, 2019 novel coronavirus
AAV2, Adeno-associated virus
AP-MS, Affinity purification-mass spectrometry
ARDS, acute respiratory distress syndrome
ARDS, adult respiratory distress syndrome
BC, Betweenness centrality
BP, Biological process
CC, Cellular component
CC, Closeness centrality
CDK5RAP2, Cyclin dependent kinase 5 regulatory subunit associated protein 2
CNS, Central Nervous System
COVID-19
COVID-19, coronavirus disease-2019
DC, Degree centrality
Drug repurposing
EC, eigenvector centrality
functional annotation
GO, Gene ontology
HCMV, Human cytomegalovirus
HCV, hepatitis C virus
HIV-1, human immunodeficiency virus 1
IL-2, interleukin-2
MERS-CoV, Middle East respiratory syndrome coronavirus
MF, Molecular function
MgADP, Magnesium ADP
MgATP, Magnesium ATP
network biology
Novel coronavirus
PD-L1, Programmed death-ligand 1
PKA, protein kinase A
PPIN, Protein-Protein interaction network
PPIs, Protein-Protein interactions
Rank aggregation
RdRP
SARS-CoV-2
SARS-CoV-2, Severe acute respiratory syndrome coronavirus 2
VSV, Vesicular stomatitis virus
[DOI] 10.1016/j.ymeth.2022.03.016 PMC 바로가기 [Article Type] Article
[DOI] 10.1016/j.ymeth.2022.03.016 PMC 바로가기 [Article Type] Article
Analysis of the factors predicting clinical response to tocilizumab therapy in patients with severe COVID-19
Article
[키워드] ALT, alanine transaminase
ARDS, acute respiratory distress syndrome
AST, Aspartate transaminase
clinical response
COVID-19
COVID-19, Coronavirus disease 2019
CRP, C-reactive protein
early initiation
ePO2/FiO2, estimated arterial oxygen/fraction of inspired oxygen ratio
HCQ, hydroxychloroquine
ICU, Intensive care unit
IFN-β, interferon-β
IL-6, Interleukin-6
IMV, invasive mechanical ventilation
IQR, interquartile range
LDH, lactate dehydrogenase
LPV/r, Lopinavir/ritonavir
NAT, nucleic acid testing
OTR, oxygen therapy requirements
predictors
RT-PCR, Reverse Transcription-Polymerase Chain Reaction
SARS-CoV-2, Severe acute respiratory syndrome coronavirus 2
SCI, Significant clinical improvement
TCZ, tocilizumab
Tocilizumab
[DOI] 10.1016/j.ijid.2022.01.040 PMC 바로가기 [Article Type] Article
[DOI] 10.1016/j.ijid.2022.01.040 PMC 바로가기 [Article Type] Article
Molecular pathways involved in COVID-19 and potential pathway-based therapeutic targets
Review
[키워드] ACE, angiotensin-converting enzyme
ACE2, Angiotensin-converting enzyme-2
ADAM17, A disintegrin and metalloproteinase 17
ARDS, acute respiratory distress syndrome
AT1R, angiotensin II type 1 receptor
COVID-19
COVID-19, Coronavirus disease 2019
drug targets
ERK, Extracellular signal regulated kinase
HIF-1, Hypoxia-inducible factor 1
JAK/STAT, Janus kinase/signal transducer and activator of transcription
JNK, Jun N-terminal kinase
MAPKs, mitogen-activated protein kinases
Molecular pathway
mTOR, Mammalian target of rapamycin
NF-κB, nuclear factor κB
NLRP3, NOD-like receptor family pyrin domain containing 3
PAMP, Pathogen-associated molecular patterns
PARG, Poly (ADP-ribose) glycohydrolase
PARP-1, Poly ADP-ribose polymerase-1
PRRs, Pattern Recognition Receptors
RAS, Renin-angiotensin system
SARS-CoV-2
SARS-CoV-2, Severe acute respiratory syndrome coronavirus 2
TLRs, Toll-like receptors
TMPRSS2, Transmembrane Protease Serine 2
TNF-α, tumor necrosis factor alpha
TRPM2, Transient receptor potential melastatin type 2
[DOI] 10.1016/j.biopha.2021.112420 PMC 바로가기 [Article Type] Review
[DOI] 10.1016/j.biopha.2021.112420 PMC 바로가기 [Article Type] Review
Impaired innate antiviral defenses in COVID-19: Causes, consequences and therapeutic opportunities
Review
[키워드] ACE-2, Angiotensin-converting enzyme 2
Antiviral innate immunity
ARDS, acute respiratory distress syndrome
CoV, coronavirus
COVID-19
COVID-19, Coronavirus disease 2019
CRS, Cytokine release syndrome
IFN, interferon
IL, interleukin
interferons
IRF, Interferon regulatory factor
ISG, Interferon-stimulated gene
JAK, Janus kinase
KPNA2, karyopherin α2
LY6E, lymphocyte antigen 6 complex, locus E
MAVS, mitochondrial antiviral-signaling protein
MDA5, melanoma-differentiated gene 5
MERS, Middle East respiratory syndrome
N/L, neutrophil to lymphocyte
NF-κB, nuclear factorκB
NSP, non-structural protein
OAS, Oligoadenylate synthetase
ORF, open reading frame
pDC, Plasmacytoid dendritic cell
PRR, pattern-recognition receptor
RIG, retinoic acid-inducible gene 1
RLR, RIG-I like receptor
S, spike
SARS-CoV-2
SARS, Severe acute respiratory syndrome
STAT, Signal transducer and activator of transcription
TBK1, TANK binding kinase 1
TLR, Toll-like receptor
TMPRSS2, Transmembrane serine protease 2
TNF-α, tumor necrosis factor alpha
[DOI] 10.1016/j.smim.2021.101522 PMC 바로가기 [Article Type] Review
[DOI] 10.1016/j.smim.2021.101522 PMC 바로가기 [Article Type] Review